Mr. Raineri is the Chief Technology Officer for Aspen Neuroscience, Inc.  He is responsible for the Manufacturing, Process and Analytical Development, Technology Development, and Delivery Device functions of a leading autologous iPSC derived cell therapy company targeting CNS diseases.  Kim is a board member observer of Cell X Technologies and a member of the Alliance for Regenerative Medicine’s Regulatory CMC Advisory Group.